Psoriasis is recognised as a chronic inflammatory immune-mediated multisystem disorder,1 affecting the skin, nails, and joints. This session provides a comprehensive overview of the epidemiology, types, and clinical manifestations of childhood psoriasis compared to adult onset, severe forms of the condition in children, associated comorbidities, differential diagnosis, treatment algorithms, challenges in paediatric psoriasis management, and the FDA and EMA approved medications, focusing on complex cases.